Primary brain cancers:

A malignant brain tumor originating from our brain is referred to as primary brain cancer. This type of brain cancer occurs less frequently compared to secondary brain cancers. A primary brain cancer can begin from different parts of our brain. Primary tumors of the brain are mostly treated using radiotherapy and chemotherapy; surgery is done only if the tumor is located in an area from where it can be removed safely.

As mentioned earlier, primary brain cancers can begin from different tissues of the brain. A lymphoma begins from the lymphocytes; the pineal gland tumors originate from the patient’s pineal gland; a meningioma starts from the meninges; pituitary adenoma originates from out pituitary gland’s surface cells; schwannoma is the brain cancer types originating from myelin sheath of axon of neurons; acoustic neuroma begins from our vestibulocochlear nerves; glioblastoma multiforme, a cancer type beginning from glial cells of cerebrum. The other brain cancer types affect more than one part of brain at a time. Astrocytomas affect the spine, brain stem, white matter and cerebellum. Brain stem gliomas can occur in more than one part of our brain stem for instance midbrain, pons and medulla. Choroid plexus papillomas affect different ventricles of our brain. The ependymomas occur in our spine’s central canal and within ventricle membranes.

Secondary brain cancers:

This brain cancer type occurs due to metastases of some other cancer type. Secondary brain cancers occur when a portion of original cancerous tumor moves along our bloodstream through lymphatic system for invading our brain, where cancerous cells fabricate another tumor. Diagnosis revealing occurrence of multiple tumors in our brain generally vouches for a secondary brain cancer.  Common cancer types metastasizing to our brain are: breast cancer, colon cancer, bowel cancer, lung cancer, skin cancer and kidney cancer.

The working team comprising of thirty-one researchers spanning fourteen nations who lately met stated that an evaluation of all the obtainable medical proof indicated that cell phone usage ought to be categorized as so-dubbed ‘possibly-carcinogenic’.

Researchers stated that the categorization which places cell phone usage in the analogous broad cancerous risk group at par with chloroform, coffees & Pb (lead) might well impel the UN health body into re-looking its parameters on mobiles.

However, far extensive & in-depth studies are necessary prior to a more definite response on any association could be furnished.

The World Health Organization earlier stated that there wasn’t any recognized proof of an association amid cancer & mobile usage.

During a telephone briefing J. Samet from the IARC explained that following review of all the pertinent proof the group categorized RF electro-magnetic fields as perhaps cancer-causative to human-beings. He stated that some proof indicated an association amid an augmented risk of developing gliomas, a brain cancer form & usage of cell phone.

The WHO’s stand has been eagerly anticipated by cell phone firms & by campaigning parties that have worries regarding whether mobiles may harm health.

Business sets soon started down-playing the conclusion with stress on the likely carcinogenic categorization additionally including items like veggies (post-pickling) & coffees.

However, according to VP, J. Walls of the CTIA, U.S. such IARC categorization doesn’t translate to mobiles causing cancer. He pointed out that the working group didn’t carry out any novel studies, though just did a review of printed trials & stated that other regulatory groups like the United States FDA has said that the weight of systematic proof hasn’t associated mobiles with any health issues. The IARC has solely unearthed the likelihood of a risk & whether or not it is representing a risk needs additional methodical probe.

The IARS’s statement ensue a trial printed in 2010 that examined nearly 13000 people using mobiles over a decade & not finding an apparent resolution on whether cell phones were causal to tumor formations in the brain.

Several past trials too haven’t been able to prove any lucid cancer association; however a United States trial during Feb. discovered that the usage of mobiles could alter brain cells activity.

The usage of mobiles has risen enormously ever since they were introduced in the earlier to middle part of the eighties. Presently, there are approximately five billion cell phone users across the globe.

Experts have stated that it is crucial to be taking realistic pre-emptive measures for reducing exposures like emphasis on texting or use hands free device. They also believe that further studies need to be carried out especially on the lasting & heavy usage of mobiles.

The Food and Drug Administration gave its approval to the gadget for brain cancer treatment in patients suffering from aggressive tumors in the brain which had relapsed following chemotherapy sessions & several interventional approaches.

Trials have shown that individuals on whom the tool was deployed had approximately similar survival of 6 months as chemotherapy takers, though experienced considerably lesser bothersome side-effects.

A decades-long awareness among physicians about cancer treatment basically revolves around trio methods – radiotherapy, medications or surgical intervention. But, the NovoTTF is representing a 4th treatment strategy.

The handy Novocure gadget deploys electrical fields to deter cancerous cells in dividing which is believed to facilitate growth & metastasis. The electrical fields were found to have hardly any impact on normal cells since these are dividing at a comparatively slackened pace, if at all.

Doctor H. Engelhard, Asst. Prof. of Neurosurgery from Univ. of Illinois who assisted in conducting the trial though didn’t receive any reimbursement from the maker Novocure spoke about the rationale for this discovery being so enthralling is that they have garnered the agency’s consent for a entirely new-fangled brain cancer treatment. He added that their research team were firstly cynical though after seeing the scans he believes that the device does actually annihilate cancerous cells in brain cancer patients.

The 6 lbs. weighing tool could be easily carried in a smallish handbag by a patient. The electric currents are emitted by the tool to 4 electrodes that are affixed to the bald head of patients.

An advisor board to the agency gave a narrow vote of seven-six favouring the efficacy of NovoTTF in March. The FDA doesn’t need to be essentially following these suggestions, although it mostly is observed to do it.

The trial which enrolled 237 patients found a survival advantage for entrants deploying NovoTTF in comparison to chemotherapy takers. The duo sets were found to live just past 6 months, on the whole. But, the NovoTTF group cited better quality of existence & didn’t experience chemo side-effects like feeling nauseous, infections & diarrhea.

The NovoTTF has been found to be as effectual or excelling whatever has been attempted till now when standard therapy fails.

Termed Glioblastomas, the condition is a highly aggressive brain cancer type & observed five yr. survival rate has been merely two per cent in sufferers past their mid-forties, as per estimates furnished by the ACS. Glioblastomas afflict around ten thousand people in the United States annually.

Benchmark therapy is 6-week long elevated dosage of radiation alongside chemo drug & then further chemo sessions for a minimum of 6 months or till tumors no more show response.

The outcomes of this landmark trial have appeared on line in ‘Cancer’ medical journal in the Mar. end edition.

Malignant glioma is a tumor which arises in the spinal or brain area & is a mostly a non-curable form of cancer having pitiable outlook. An approximate ten thousand people in the U.S. are identified with this condition annually & their avg. 1-yr. survival rate is around fifty per cent. Lab trials have found that manufactured hypericin has strong inhibitory action on the development of gliomas, partly because of their stalling effect on an enzyme family which encourages tumor propagation, protein kinase C.

Helming the trial, W.T. Couldwell, Prof. from the Univ. of Utah School of Medicine states that since this St. John’s Wort compound has been found to yield remarkable outcomes in halting cancerous development of gliomas in the lab, they were keen on examining how safe it was & its likely tumor-busting activity in patients having recurring brain tumor.

During the course of this trial, Couldwell & his group of Canadian & American researchers did an oral administration of artificial hypericin to patient groups having duo glioma forms – namely glioblastomas & anaplastic astrocytomas – in whom tumors have relapsed or advanced in spite of standard therapy. For evaluating how safe & ably tolerated the medicine was, trial scientists offered the patients eventually higher doses of the artificial hypericin & then closely monitoring them for any detrimental side-effects. Nearly 40% of the trial entrants were noted to have completed their 3-month therapy regime, proving that the St. John’s Wort compound is ably tolerated as an orally given drug in such patient set.

The trial team even did an examination of responses to therapy in this set of brain tumor patients. They noted that twenty-two per cent of all the trial entrants attained either stabilized condition or partially occurring responses in the course of therapy with this compound. From the eighteen patients who did finish taking their sixty days medicine course of hypericin therapy, half of them attained stabilized condition or partially experienced responses.

Patients partaking in this trial were individuals in whom tumors had relapsed or advanced following extensively done past treatment, the lead author stated. He concluded that proof of likely tumor-fighting activity in such sick populace of patients who met with failure when conventionally done therapy was offered is optimistic news that hypericin could be beneficial as an add-on in the present standard-of-care.

Characteristically, treatment for glioma entails a combo of surgery, radiotherapy & chemotherapy. Researchers indicate imminent usage of the compound in treating malignant glioma in conjunct with radiotherapy or some chemotherapy agents or among patients having tumors that have developed resistance to therapy.

As diverse chemotherapy agents have differing mechanism of action, scientists would be finding it quite intriguing to observe whether the addition of hypericin to existent therapy regimes for malignant gliomas will be having a stabilizer impact or capable of producing synergy.

Leksell gamma knife is the sole radiation treatment method that has garnered the Food and Drug Administration approval for treating brain metastases. It is a corroborated radiation therapy system exclusively devoted to treatment of the vastly sensitive part of our bodies – the brains.

Gamma knife surgery is a mild, outpatient therapy approach causing miniscule or zero pains & lasts for a duration of just some hours. The treatment facilitates patients in maintaining quality of existence or returning instantaneously for primary cancer treatment.

The answer to Gamma knife surgery being so successful is its capability of precisely focussing several elevated-intensity gamma-radiation shafts to congregate on a single or multiple tumors. Every single ray is comparatively low-energy hence the radiation has almost no impact on regular brain tissues.

Gamma Knife Surgery Plus Points

• It is a non-invasive procedure and unlike what it is called, it is knife-less. Gamma knife is the term used due to its operative accuracy & efficacy. It is a slit-free, bloodless & complication-free surgery.
• Research findings reveal that confined control – which means the particular tumor undergoing treatment doesn’t recur – surpasses an avg. of eighty-five percent for managing tumors in any site in the brain.
• It is a substantiated method and over two thousand research papers have been printed about this surgery & over five lakh patients have undergone this treatment globally.
• There isn’t any radiotherapy that has accuracy paralleling Leksell Gamma Knife.
• The non-invasive method is capable of isolating & delivering an elevated radiation dosage to a single or multiple brain tumors in a solo therapy sitting.
• Majority of the individuals get discharged from health centers on the analogous day & are capable of resuming regular tasks within a single or duo days.
• Least extent of associated side-effects with the Leksell Gamma Knife and easily allayed with the use of OTC pain-killer. Hair fall, feeling nauseous are symptoms which are not experienced as is the case with several therapies.
• It is a very versatile surgery that could be employed for treating cancer that has metastasized in operatively non-accessible regions of the brains, like the brain stem.
• For those patient types with newly developed brain metastases re-treatment using Gamma Knife surgery is a feasible option.

Why Isn’t Gamma Knife Not being Used by All and Sundry

Not every person is an entrant for this procedure. Moreover, only some surgeons have the training for using it or having admittance to it. Hence they might show reluctance in recommending it to patient types.

There are other forms of radiotherapy which are mostly claiming to have accuracy & efficacy; however they do not possess the information & corroborated outcomes as that of Leksell Gamma Knife.

How is brain cancer diagnosed?

If a person is found the victim of a brain cancer, the healthcare provider for brain cancer diagnosis may go for an X-ray in the initial stage of the cancer. However, the X-ray may not show a perfect result and thus, a Computerized Tomography or CT Scan of brain nerves is more comfortable. Before the CT scan, the physical experts will inject a harmless dye inside the veins of the patient. This dye helps to have clear picture of the brain nerves in the scanning device. The patient is also advised to go for a regular check up to have a look on the other complications in the health.  Brain cancer diagnosis includes blood test which is also very useful including the tests for liver functioning and the level of electrolytes. The patient who is suffering with changing mental conditions, the blood and urine test is done to observe the changes in the blood stream and the affect of the drugs. The other advanced process of brain scan is known as the magnetic resonance imaging or MRI Test. The MRI Test recognize the condition of assorted tumors inside the brain like area surrounded the brain, the parts of brain coverings, the spaces of cerebrospinal fluid  and other vascular structure. In an advanced stage, a small part of the tumor inside the brain is taken out and tested under a microscope. This process needs a surgery. In some cases, the surgery may not be required. Here, the physician may make hole on the skull and slots in a needle to take the sample of the tumor. This method is medically known as stereotaxis or stereotactics. This test is known as a biopsy test.

The treatment process:-

Medical experts say that brain cancer is treated through the condition, shape and size of tumor inside the brain. The physicians also verify the age and other health condition of the patient. The location of the tumor inside the brain is also justified before a treatment is started.  Usually, in the brain cancer treatment process, the medical experts use chemotherapy drugs for a fixed period. If the chemotherapy drugs do not work, the patient is treated with other treatment methods, which include a radiation therapy. The radiation therapy gives the rays of electronic radiation on the affected part or the tumors. This therapy helps to kill the cancerous cell and tumor growth inside the brain. The advanced cancer is treated through a surgery.

Natural Treatments:-

The natural treatment process of Ayurveda provides medicines as per the dosha like the Vata , Pitta and Kafa. Some of the Ayurvedic medicines are shown significant result in the treatment of cancer like the Laksha Gugglu, Aabha Guggulu, Trifala, Shilajatu Vati, Bhallatak Phalmajja Churna , Tribhang Bhasma , Arogya Vardhini etc. Most of the guggulu measures are  useful to reduce the pain and the growth of cancer cells. The National Cancer Institute has recommended some of the means of aromatherapy and essential oil and a great source of relief in the cancer patients. The combination of a number of herbs, flowers, leaves and other natural extracts give a profound relaxation to devout, physical and emotional values. A massage therapy through the essential oils has recommended as a standard way of treatment. In the United States , the essential oil are used in the topical and inhalation treatments for cancer. Theses oils are also given through injection. Some of the essential oil also given a proper stimulation to the body and are recommended by the US Food and Drug Administration.

Some researches:-

Brain cancer has also gone through lots of researches like in the year 1990 , the scientists in the University of Kentucky had discovered that the patient who go through adopt the treatment of radiation therapy and chemotherapy together get a positive result and relaxation. The National Institute of Health later discovered a new treatment therapy with herpes genes for cancer patients, especially, who do not bear the chemotherapy and radiation therapy. In the year 2002, a research revealed that the children who come in the connection with some type of bacteria, may develop the astrocytoma and ependymoma segment of cancer cells in the brain. An excessive usage of cell phones can also develop the condition of brain cancer , found a report in the London institute of Cancer Research. Another research found the considerable brain cancer treatment through DNA-Disruption process with  the doses of Temozolomide. The patient who suffer with the disease should get a complete support from the family members and friends.

Brain Cancer – Part 1

A cancer in brain is not only an issue for medical researches; it has also been interestingly portrayed in many of the stories and novels.  Recently, the annual meeting of the National Brian Tumor’s Society or NBTS, in the USA discussed lots of issues related to a brain cancer. The NBTS had also announced the month of September as a Children cancer consciousness month and organized many camps and conferences to spread the knowledge among a number of people globally. The medical experts in the University of Alberta are also working on various treatments and therapies for a brain cancer. They also have launched the Orphan Generic Drug Dichloroacetate or DCA as a treatment, says a resource.  This year, the Third Annual Brain Cancer Walk was also processed by the Seattle center with the co-operation of other local groups; the walk had an aim to give support to those affected people who suffer with the problem each year and do not get a proper treatment.

What is a brain cancer growth?

Like other type of cancer, the brain cancer also bears an unusual growth of cells inside the brain diagram. The cancer can also develop and spread in the other parts of the body and even in the blood vessels. Some of the brain cancers can be in the form of tumors. The tumors can be either severe or mild.  The condition of a brain cancer can be observed if any of the brain cells losses its normal volume. The abnormal cells of the brain cancer, expands in a numerous cells and turn into a bunch of cells.  The National Cancer Institute has coated that the grade or segment of a brain cancer always depends upon the growth of the cancerous cells. The brain cells can grow either due to the benign or the malignant tumors. Some of the tumors like Metastatic tumors of the brain have a great risk of developing the condition of a brain cancer.  A cancer of brain can grow due to so many reasons. It can grow among those people who work in extreme humidity or toxic environments of if some one has a genetic History of brain cancer.   The people who smoke a lot or have a habit of drinking alcohol excessively can also suffer with it. The people who have an HIV infection can easily develop tumors or cancers in the brain cells and nerves.

Warning Signs:-

People suffering with a brain cancer may not have any sign in the earlier stage. There are cases where the cancer of a brain cell has been recognized in a last or advanced stage. When the tumors start affecting the other inner parts of the brain, the person may start getting the symptoms. In a first stage, the person may have swellings in and around the cells and thus, he may have severe headaches and cramps in the brain muscles, he may also look extremely fragile. The patient may also face difficulties in walking or concentrating on various works. Usually, the patient of a brain cancer may not tolerate light and noise. He can have difficulties in moving his body muscles and frequent seizures.  The cancer development in brain mainly affects the memory power or alertness of a person. If the cancer goes untreated, the patient will also have vomiting and nausea, problems in vision and conversation. The untreated condition of a cancer will also lead to stroke or coma.

Brain Cancer – Part 2

Intensity modulated arc therapy method is reliant on novel attributes of the newest generation of X-ray treatment device which provide X ray sources in continually rotating varied directions encircling the patient at the time of therapy. This technique helps to increase directions from which the X-ray beams are coming from.

The research that was carried out by physical scientists from the St. Jude Children’s Hospital located in Memphis Tennessee carried out comparisons in between varied therapy approaches inclusive of the intensity modulated arc therapy for 9 kids who were undergoing radiation therapy treatment for brain cancer. The study investigators observed that IMAT was capable of irradiating such brain tumors and also reduced general exposure to the adjoining healthy tissues.

Chris Beltran, a medical physicist from St. Jude Children’s Hospital and presenter of the research in Philadelphia stated that the study intended on reducing radiation dosage which was undoubtedly better for the patients.

Cancer treatment via radiation therapy could be complex in case of particular forms of tumors which are encased by sensitive normal cells. A number of brain tumors, for example, are deeply set within the cranium and might need the X-rays to penetrate via crucial body parts such as the eye, ear and sections of the brain.

The X-rays emitted during radiation therapy are capable of damaging such body constitutions that could cause permanent side effects due to the treatment. When ionizing X-rays are sent via the ear, they might harm the cochlea and cause long-standing auditory failure. Similarly, when the temporal lobes of the brain are exposed to the X-rays during radiation therapy it could lead to intellectual ability loss.

According to Chris Beltran, current gear for administering radiation therapy facilitates continual movement of X-ray source around the person. It thus offers the liberty to select the source location of the X-ray beams.

Beltran’s study has suggested that a therapy plan inculcating intensity modulated arc therapy would aid in sparing the sensitive healthy normal tissues. Employing prevalent measures which associate radiation dose to tissue harm, Beltran forecasts that the intensity modulation arc therapy plan could help in curbing auditory loss and harm to the temporal lobes in the brain in comparison to other therapy plans.

These findings offer both novel percipiency into behavioural pattern of gliomas alongside prospective novel medicine targets and therapy approaches.

The outcomes indicate that EGFR being expressed is crucial to tumor growth and researchers have shown for the foremost instance that there are means which tumors employ for circumventing the necessity for the receptors. Investigators added that other types of cancers could employ analogous approaches and that further investigation is needed for finding out in detail regarding the signalling alleyways which brain tumors employ for getting about targeted therapies like those focussed at EGFR.

In belligerent forms of gliomas, additional replicas of the EGFR gene are manufactured, and half the populace of these tumors additionally hold an EGFR mutation, that augments tumor development and foreshadows a poor recovery. Clinical studies of anti-EGFR agents have shown little success; brain tumors might show initial response, however afterwards show resistance to the medicines.

The group of researchers with intentions of finding out whether mutant EGFR was required by tumors for their continual development, produced a heritable system among mice wherein they were capable of controlling the extent to which mutated EGFR could be expressed, switching it on or off employing the medicine tetracycline. They observed that when EFGR was obstructed by tetracycline, tumor development would halt, analogous to patients that responded to EGFR inhibitors. However, the tumors would begin re-growing in spite of absence of EGFR translating to the fact that some other factor was eliciting tumor augmentation.

The investigators scrutinized individual tumors which had circumnavigated or managed to escape the requirement for mutant EGFR for sustaining their growth. In a number of situations, tumors which could generally have terminated mice in twenty days were in stabilised state for a span of months with the clogged-up EGFR expression.  The investigators employed microarray expertise for testing for genes which earlier did not have any expression in the tumors, however whose over-expression was noted in tumors which no more needed EGFR. The scientists subsequently observed that on encumbering KLHDC8, tumor development stopped which was a realistic target.

The researchers concluded that in case the tumors employed similar approaches for getting around receptor inhibitors, then aiming for that substitute conduit along with the receptor would offer lengthier responses as it would hit the chief occurrence along with the getaway course.

• The symptoms arise due to the pressure caused by the tumor or infringing on other areas of the body and hampering their normal functioning.
• Few of the symptoms occur due to the swelling in the brain because of the tumor or neighbouring inflammation.
• The signs of primary and metastatic brain cancers are analogous.

The below stated signs of brain tumor are most prevalent:

• Headaches.
• Feeling weak.
• Ungainliness.
• Problems faced when walking.
• Seizures.

Other kinds of non-definite symptoms comprise of:

• Modified mental standing – Alteration in concentration levels, memory and attentiveness.
• Feeling nauseous, vomiting – particularly occurring in the early dawn hours.
• Anomalous vision.
• Speech difficulties.
• Eventual variation in logical or emotional ability.

In several individuals the inception is quite slow and could be overlooked by both the individual having the brain tumor and the kin. On occasions, such symptoms arise more swiftly. In some occasions, the individual would act like he/she is getting a stroke.

Brain Tumor Symptoms

It is imperative to seek medical advice in case one is having the below mentioned symptoms:

• Inexplicable continual vomiting.
• Dual vision or inexplicable blurred vision, particularly just on one side.
• Feeling lethargic or increasingly sleepy.
• Newly arising seizures.
• Novel pattern or kinds of headaches.

Though headaches are considered the prevalent symptom of brain cancer, they might not arise till the advanced stages of the disease. In case there is a major variation in the pattern of headaches, then the healthcare provider might advice visiting the hospital.

In case one has a detected brain tumor then any newly occurring symptoms or comparatively abrupt or swift deterioration of symptoms must be immediately shown to the doctor. One must be vigilant about the following newly arising symptoms:

• Seizure attacks.
• Variations in mental status like feeling increasingly sleepy, memory issues or difficulty in concentrating.
• Ocular variations or other sensory issues.
• Speech problems or difficulty to express oneself.
• Feeling clumsy or problems faced when walking.
• Feeling nauseous or vomiting (particularly among individuals in their middle age or the elderly).
• Abrupt inception of fever, particularly subsequent to chemotherapy.

Diagnosis & Tests

The outcome of the medical interrogation and physical exam would possibly indicate the presence of a problem in the brain or brain stem.

• CT scan
  In majority of the situations, a brain CT scan would be performed which is much alike an x-ray but renders more detailed imagery in three-dimensional form. Generally, a nontoxic dye is given via injection into the bloodstream for highlighting the anomalies on the scan.
• Regular Lab Analysis Tests
  Individuals having brain cancer mostly have other medical issues, hence regular laboratory tests would be carried out. These comprise of blood analysis tests for checking blood, electrolytes, tests for checking liver functioning and a blood coagulation report. In case one is having a mental condition variation as the key symptoms then blood or urine analysis could be performed for detecting drug usage.
• MRI Scan
  An increasing number of MRI scans are conducted as compared to CT scans for doubtful cases of tumors in the brain due to higher level of sensitivity in detection of tumor that are present or variation in the tumor. Presently, many institutions continue to employ CT scans as the foremost diagnostic tests. X-rays of the skull are not prevalently carried out for brain cancer diagnosis.

In case the scans are indicating that a brain tumor is present, then a referral to a cancer specialist or oncologist would be done. In case there are none available in one’s locality then in such a situation a referral to a brain tumor specialist (neuro-oncologist) would be done.

The subsequent diagnostic step would be corroborating that cancer is present for which a small tissue sample of the mass via biopsy procedure is done for identifying the form of tumor.

• The prevalent technique employed to obtain a biopsy is surgery, the skull being opened generally for removal of the entire tumor in case doable. A biopsy is then removed from the tumor.
• In case the surgeon is not able to take out the complete tumor, then a minuscule part of the tumor is removed.
• In some situations, the biopsy sample could be taken with no need to open the skull. The precise site of the tumor present in the brain is ascertained by stereotactic means by employing CT or MRI scans during which the head is to be maintained motionless. A tiny puncture is done in the skull through which a needle is steered till it reaches the tumor in order to collect the biopsy sample and is then taken out. This approach is known as stereotaxis or stereotactic biopsy.
• The biopsy sample is microscopically evaluated for detecting any cancerous presence.